The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells
Abstract Aberrant microRNA expression contributes to breast cancer progression and endocrine resistance. We reported that although tamoxifen stimulated miR-29b-1/a transcription in tamoxifen (TAM)-resistant breast cancer cells, ectopic expression of miR-29b-1/a did not drive TAM-resistance in MCF-7...
Guardado en:
Autores principales: | Penn Muluhngwi, Negin Alizadeh-Rad, Stephany L. Vittitow, Ted S. Kalbfleisch, Carolyn M. Klinge |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8b5d06132f984ad69c6ad61231253870 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
por: Carolyn M. Klinge, et al.
Publicado: (2021) -
The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas.
por: Tali Avnit-Sagi, et al.
Publicado: (2009) -
Huaier extract restrains the proliferative potential of endocrine-resistant breast cancer cells through increased ATM by suppressing miR-203
por: Sumei Gao, et al.
Publicado: (2017) -
miR-29b contributes to multiple types of muscle atrophy
por: Jin Li, et al.
Publicado: (2017) -
Circulating miR-21, miR-29a, and miR-126 are associated with premature death risk due to cancer and cardiovascular disease: the JACC Study
por: Hiroya Yamada, et al.
Publicado: (2021)